Tanım

Adhesive bandages are designed to protect the wound from further injury, infection, and dirt. They create a barrier that prevents bacteria and other harmful substances from entering the wound and causing further damage. They also help to keep the wound moist, which can promote faster healing. There are many different types of adhesive bandages available, including those made from plastic, fabric, or silicone. They come in various shapes and sizes, from small circular bandages to larger rectangular ones. Some adhesive bandages are also infused with medications, such as antiseptics or pain relievers, to provide additional protection and comfort. The adhesive bandages market in Asia Pacific is likely to register a CAGR of over 4.2% with an incremental growth of USD 175.6 million during the forecast period 2023-2028.

Rapor, döneme ilişkin güncel pazar büyüklüğü verilerini sağlar 2019-2022 ve tahmin 2028 covering key market aspects like sales value and volume for adhesive bandages. The Asia Pacific adhesive bandages market is segmented on the basis of distribution channel, and country. Dağıtım kanalına göre, the adhesive bandages market in Asia Pacific has been segmented into grocery stores and supermarkets, drug stores and pharmacies, e-ticaret, ve diğerleri. In terms of geography, the adhesive bandages market in Asia Pacific has been segmented into Australia, Çin, Hindistan, Endonezya, Japonya, Filipinler, Güney Kore, Tayland, Vietnam, ve diğerleri.

The Asia Pacific adhesive bandages market is highly competitive. Top players covered in Asia Pacific Adhesive Bandages Market Study are 3M Company, Band Doctor Co. Ltd., Beiersdorf AG, CG Bio Inc., Convatec Group plc, Forest Holdings Inc., Fujimoto Holdings Co. Ltd., Glory Ray Holdings Limited, Hakujuji Co. Ltd., Ildong Pharmaceutical Co. Ltd., Jack Chia Industries (Tayland) Public Company Limited, Johnson & Johnson (J&J), JW Shinyak Corporation, Kobayashi Pharmaceutical Co. Ltd., Mundipharma International Limited, NICHIBAN Co. Ltd., Paul Hartmann AG, Sato Pharmaceutical Co. Ltd., SinSin Pharmaceutical Co. Ltd., Smith & Nephew plc, Yunnan Baiyao Group Co. Ltd., Yutoku Pharmaceutical Ind Co. Ltd..

Rapor, bu sektörde faaliyet gösteren şirket ve kuruluşlar için paha biçilmez bir kaynaktır. It provides a cohesive picture of the adhesive bandages market to help drive informed decision making for industry executives, kural koyucular, akademik, ve analistler.

Rapor Kapsamı

Dağıtım kanalı: grocery stores and supermarkets, drug stores and pharmacies, e-ticaret, ve diğerleri
Ülke: Avustralya, Çin, Hindistan, Endonezya, Japonya, Filipinler, Güney Kore, Tayland, Vietnam, ve diğerleri
Dikkate alınan yıllar: bu rapor dönemi kapsamaktadır 2019 ile 2028

Paydaşlar için Temel Faydalar

Get a comprehensive picture of the Asia Pacific adhesive bandages market
Yerel verilere dayanarak bölgesel stratejiler ve stratejik önceliklerin belirlenmesi
Büyüme sektörlerini ve yatırım eğilimlerini belirleyin

İçindekiler

1. Market definition
2. Araştırma metodolojisi
3. Market overview
4. Adhesive bandages market by distribution channel
4.1 Grocery stores and supermarkets
4.2 Drug stores and pharmacies
4.3 E-ticaret
4.4 Diğerleri
5. Adhesive bandages market by country
5.1 Avustralya
5.2 Çin
5.3 Hindistan
5.4 Endonezya
5.5 Japonya
5.6 Filipinler
5.7 Güney Kore
5.8 Tayland
5.9 Vietnam
5.10 Diğerleri
6. Company profiles
6.1 3M Company
6.2 Band Doctor Co. Ltd..
6.3 Beiersdorf AG
6.4 CG Bio Inc.
6.5 Convatec Group plc
6.6 Forest Holdings Inc.
6.7 Fujimoto Holdings Co., Ltd..
6.8 Glory Ray Holdings Limited
6.9 Hakujuji Co., Ltd..
6.10 Ildong Pharmaceutical Co., Ltd..
6.11 Jack Chia Industries (Tayland) Public Company Limited
6.12 Johnson & Johnson (J&J)
6.13 JW Shinyak Corporation
6.14 Kobayashi Pharmaceutical Co., Ltd..
6.15 Mundipharma International Limited
6.16 NICHIBAN Co., Ltd..
6.17 Paul Hartmann AG
6.18 Sato Pharmaceutical Co., Ltd..
6.19 SinSin Pharmaceutical Co., Ltd..
6.20 Smith & Nephew plc
6.21 Yunnan Baiyao Group Co., Ltd..
6.22 Yutoku Pharmaceutical Ind Co., Ltd..
7. Appendix
7.1 StratejiHelix Hakkında
7.2 Sorumluluk reddi beyanı